Recruiting
Phase 1

B7-H3 CAR T Cells

Sponsor:

Crystal Mackall, MD

Code:

NCT06500819

Conditions

Neuroblastoma

Sarcoma

Osteosarcoma

Eligibility Criteria

Sex: All

Age: 2 - 30

Healthy Volunteers: Not accepted

Interventions

B7-H3CART Dose (Intravenous)

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-12-15. This information was provided to ClinicalTrials.gov by Crystal Mackall, MD on 2025-04-24.